EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease

Adel A Yafarova, Elena V Dementeva iD, Olga A Zlobovskaya iD, Anna F Sheptulina iD, Elena V Lopatukhina iD, Yuriy S Timofeev, Evgeniya V Glazunova iD, Aleksey V Lyundup, Yuriy V Doludin iD, Anton R Kiselev iD, German A Shipulin, Valentin V Makarov und 2 weitere

International Journal of Molecular Sciences · 20.10.2024 · 25 (20) · 11295

DOI: 10.3390/ijms252011295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.10.2024. Verfasst von Adel A Yafarova und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center for Therapy and Preventive Medicine, Petroverigskyj Lane 10, Bld. 3, 101990 Moscow, Russia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Coronary Artery Disease, Heart Failure. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation, Ministry of Health of Russia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the role of gut microbiota in cardiovascular diseases, with an additional focus on pro-atherogenic metabolites. We use advanced network analysis and machine learning techniques to identify key microbial features linked to coronary artery disease (CAD) and heart failure with reduced ejection fraction (HFrEF). This cross-sectional study included 189 participants divided into three groups: coronary artery disease (n = 93), heart failure with reduced ejection fraction (n = 43), and controls (n = 53). Assessments included physical exams, echocardiography, dietary surveys, blood analysis, and fecal analysis. Gut microbiota composition was analyzed using next-generation sequencing (NGS) and quantitative polymerase chain reaction (qPCR). Statistical analysis methods for testing hypotheses and correlations, alpha and beta-diversity analyses, co-occurrence networks, and machine learning were conducted using Python libraries or R packages with multiple comparisons corrected using the Benjamini–Hochberg procedure. Significant gut microbiota alterations were observed, with higher Bacillota/Bacteroidota ratios in CAD and HFrEF groups compared to controls (p < 0.001). Significant differences were observed in α-diversity indices (Pielou, Chao1, Faith) between disease groups and controls (p < 0.001). β-diversity analyses also revealed distinct microbial profiles (p = 0.0015). Interestingly, trimethylamine N-oxide (TMAO) levels were lower in CAD and HFrEF groups compared to controls (p < 0.05), while indoxyl sulfate (IS) levels were comparable between the study groups. Co-occurrence network analysis and machine learning identified key microbial features linked to these conditions, highlighting complex interactions within the gut microbiota associated with cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeCoronary Artery DiseaseHeart FailureHumansMaleFemaleMiddle AgedAgedCross-Sectional StudiesMethylaminesMachine LearningFecesHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

alpha-diversitybeta-diversitycardiovascular biomarkerscoronary artery diseasedysbiosisgut microbiotaheart failuretrimethylamine-N-oxide

Substanzen

Methylaminestrimethyloxamine

Autor:innen und Institutionen

  • National Medical Research Center for Therapy and Preventive Medicine, Petroverigskyj Lane 10, Bld. 3, 101990 Moscow, Russia.
  • Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency, Pogodinskaya Str., 10/1, 119121 Moscow, Russia.
  • Endocrinology Research Centre, Dmitry Ulyanov St. 19, 117036 Moscow, Russia.

ORCID-Profile: Elena V Dementeva, Olga A Zlobovskaya, Anna F Sheptulina, Elena V Lopatukhina, Evgeniya V Glazunova, Yuriy V Doludin, Anton R Kiselev, Oxana M Drapkina, Sergey M Yudin

Förderung

  • Ministry of Science and Higher Education of the Russian Federation
  • Ministry of Health of Russia

Zitieren

APA

Yafarova, A. A., Dementeva, E. V., Zlobovskaya, O. A., Sheptulina, A. F., Lopatukhina, E. V., Timofeev, Y. S., Glazunova, E. V., Lyundup, A. V., Doludin, Y. V., Kiselev, A. R., Shipulin, G. A., Makarov, V. V., Drapkina, O. M., & Yudin, S. M. (2024). Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease. International Journal of Molecular Sciences, 25(20), 11295. https://doi.org/10.3390/ijms252011295

Vancouver

Yafarova AA, Dementeva EV, Zlobovskaya OA, Sheptulina AF, Lopatukhina EV, Timofeev YS, et al. Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease. International Journal of Molecular Sciences. 2024;25(20):11295. doi:10.3390/ijms252011295

BibTeX
@article{Yafarova2024,
  author = {Yafarova, Adel A and Dementeva, Elena V and Zlobovskaya, Olga A and Sheptulina, Anna F and Lopatukhina, Elena V and Timofeev, Yuriy S and Glazunova, Evgeniya V and Lyundup, Aleksey V and Doludin, Yuriy V and Kiselev, Anton R and Shipulin, German A and Makarov, Valentin V and Drapkina, Oxana M and Yudin, Sergey M},
  title = {Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {11295},
  doi = {10.3390/ijms252011295}
}
Kostenlos starten →